Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Self-regulating hydrogel for diabetic wound healing: From animal models to a pilot clinical study. | Sci Adv | 2026 | 41920988 | PubTator, text mining | PubMed |
| [Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916916 | PubTator, text mining | PubMed |
| Interaction between high-sensitivity C-reactive protein and mean platelet volume for 1-year major adverse cardiovascular events in stable coronary artery disease. | Sci Rep | 2026 | 41904332 | PubTator, text mining | PubMed |
| AXL-Driven Stemness and Hedgehog Signaling in HER2-Positive Breast Cancer with Acquired Trastuzumab Resistance: Synergistic Potential of AXL and HER2 Co-Targeting. | Life (Basel) | 2026 | 41900890 | PubTator, text mining | PubMed |
| Gene Expression Profiles Associated with Molecular Subtypes and Pathological Response to Neoadjuvant Treatment in Surgical Breast Cancer. | Int J Mol Sci | 2026 | 41898428 | PubTator, text mining | PubMed |
| RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia. | J Exp Clin Cancer Res | 2026 | 41896977 | PubTator, text mining | PubMed |
| Endothelialized human umbilical cord mesenchymal stem cell-derived exosomes enhances angiogenesis and stabilizes the blood-spinal cord barrier after spinal cord injury. | J Nanobiotechnology | 2026 | 41888789 | PubTator, text mining | PubMed |
| GAS6 potentiates tumor progression through modulating suppressive microenvironments. | Am J Cancer Res | 2026 | 41868669 | PubTator, text mining | PubMed |
| Bone marrow SELENOP+ macrophages support hematopoiesis after transplantation via GAS6-AXL signaling pathway. | Cancer Lett | 2026 | 41862151 | PubTator, text mining | PubMed |
| Macrophage plasticity in thyroid eye disease: dual effects of inflammation and fibrosis. | Front Immunol | 2026 | 41859126 | PubTator, text mining | PubMed |
| Myeloid HDAC3 deletion protects against traumatic optic injury. | Cell Death Discov | 2026 | 41851071 | PubTator, text mining | PubMed |
| The Effects of Vitamin K2 on Recovery from Muscle-Damaging Resistance Exercise in Young and Older Adults: The TAKEOVER Randomized Controlled Trial. | Med Sci Sports Exerc | 2026 | 41843412 | PubTator, text mining | PubMed |
| Vitamin K and muscle health: mechanisms and clinical perspectives in sarcopenia and beyond: narrative review. | Front Nutr | 2026 | 41835384 | PubTator, text mining | PubMed |
| The Heterogeneity and Function of Stromal Cells in the Tumor Microenvironment. | Research (Wash D C) | 2026 | 41809407 | PubTator, text mining | PubMed |
| Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells. | Front Immunol | 2026 | 41798920 | PubTator, text mining | PubMed |
| Phytohormone Signaling Induces Dormancy and Apoptosis in Prostate Cancer Disseminated Tumor Cells. | Med Res Arch | 2026 | 41789352 | PubTator, text mining | PubMed |
| Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review. | Wound Repair Regen | 2026 | 41787822 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential. | Nat Commun | 2026 | 41781391 | PubTator, text mining | PubMed |
| Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications. | Immunohorizons | 2026 | 41774843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=3